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Supra-sellarAbstract Background: MR spectroscopy and diffusion-weighted imaging are useful non invasive
imaging modalities used for characterization of different sellar and suprasellar lesions.
Patient and methods: We studied 30 cases of suprasellar SOLs (as proved by conventional MRI),
MRS and DWI. Our ﬁndings were correlated with histopathological analysis after surgical resection.
Results: Three false positive cases in which cMRI give diagnosis mismatched with that obtained
after adding the MRS ﬁndings and ADC values. MR spectrum type IIC is found in macroadenoma,
craniopharyngioma, meningioma and germinoma with characteristic broad lipid peak in the second
and forth types and elevated alanine peak in meningioma. Glioma hadMRS appearance of type IIB.
Simple differentiation between tumor types were achieved by the mean ADC values which were sta-
tistically signiﬁcant (p< 0.001) when correlated to the histological diagnosis. When the ADC value
of 0.6 · 103 mm2/s this strongly points to macroadenoma, ADC value of 1.05 · 103 mm2/s in
meningiomas, ADC value 1.88 8 · 103 mm2/s strongly points to craniopharyngioma, while gliomas
and germinoma had ADC values 1.6 · 103 mm2/s and 1.0 · 103 mm2/s respectively.
Conclusion: MR spectroscopy and DWMRI are considered important diagnostic tools complemen-
tary to cMRI in pre-surgical evaluation and discrimination between different sellar and suprasellar
lesions.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Accurate diagnosis is essential for optimum clinical manage-
ment of patients with sellar and supra-sellar tumors. Currently,
there is a widespread use of MRI in determining tumor extent
for surgery and radiotherapy planning as well as for post ther-
apy monitoring (1–3).
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pophyseal cells (adenoma and carcinoma) and other pituitary
tumors of the sellar region that include; craniopharyngioma,
schwannomas, germ cell tumors, neuronal tumors (ganglio-
neuromas), mesenchymal tumors, gliomas, chordomas and
metastatic tumors (4).
Recently, diffusion-weighted magnetic resonance imaging
(DWI) has been used in the investigation of intracranial
tumors (5–7). DW imaging allows the measurement of tissue
water diffusion, which is affected by the size and integrity of
structures that normally restrict diffusion, in the brain. The
apparent diffusion coefﬁcient (ADC) can be increased as a
result of pathologic processes that modify tissue integrity,
and thus these processes reduce ‘‘restricting’’ barriers (8).
At present 1H-MRS represents a standard method for clin-
ical evaluation of intracranial tumors (9,10). It provides non-
invasively a wide spectrum of the biochemical information,
which can be used for differentiation of neoplastic and non-
neoplastic pathology, estimation of the tumor type, grade
and proliferative activity, prediction of the response to therapy
and prognosis, and monitoring of the therapeutic response.
The majority of published 1H-MRS studies are devoted to
investigation of parenchymal brain lesions, whereas only few
reports dealt with supra-sellar neoplasm. The reason for this
is evident––in such cases it is difﬁcult to get good quality spec-
tra, because clinical MR imagers with magnetic ﬁeld strength
of 1.5 Tesla usually do not permit to use 1H-MRS voxel, less
than 1 cc, which results in its frequent contamination with
skull base structures (11,12).
2. Patients and methods
The study was carried in the time frame between June 2012 and
September 2013, included 30 consecutive patients referred
from Neurology and Neurosurgery Departments to the MR
unit, Radiology Department, Zagazig University. All our
patients were known cases of sellar and/or supra-sellar SOL
as proved by CT and MRI. The study was approved by the
local ethics committee and informed consent was obtained
from the patients.
2.1. Imaging sequences
(1) cMRI with a 1.5 T clinical imager (Philips Medical Sys-
tem-Achiva-class II, USA) equipped with a standard
head coil. The following protocol was used:
 Non contrast axial, coronal and sagittal T1WIs (TR
400–550 m/s, TE 15 m/s, FOV 250, matrix
256 · 256, section thickness 3 mm, interslice gap
1 mm).
 Axial T2WI (TR 3500–4800 m/s, TE 110 m/s, FOV
250, matrix 256 · 256, slice thickness 3 mm, interslice
gap 1 mm).
 Post contrast coronal and sagittal T1WI after admin-
istration of gadolinium 0.1 mm/kg body weight.
(2) Prior to contrast agent administration, breath hold
DWI was done with a single-shot spin-echo echo-plan-
ner sequence (TR/TE: 2000/33–55, matrix size
128 · 128, section thickness 6 mm, interslice gap
1 mm, FOV 38 cm, b values 0 and 1000 s/mm2).(3) ADC maps were calculated automatically and ADC
values were measured by using circumferential ROI
(8–50 mm2) in the central and solid appearing portions
of lesions.
(4) Single voxel MRS was performed by applying the voxel
on the region of the interest which was the solid part of
the lesion. Single voxel acquisition was used and data
from the voxel were obtained using a point resolved
spectroscopy sequence (TR 2000 m/s, TE 135 m/s).
The time domain signal intensity was recognized and pro-
cessed to remove residual water signal. Post processing of
the spectroscopic data consisted of frequency shift and phase
and linear baseline corrections after Fourier transformation.
Frequency domain curve was ﬁtted by the manufacturer to
deﬁne metabolites. The main metabolites identiﬁed by
1H-MRS were NAA at 2.0 ppm, Cr at 3.0 ppm, Cho-contain-
ing compounds at 3.2 ppm, myoinositol (mI), lactate as a dou-
blet at 1.33 ppm and lipids resonating between 0.8 and
1.4 ppm. Presence of each metabolite peak was initially evalu-
ated qualitatively by visual inspection, and type of the patho-
logical 1H-MR spectra was determined according to the
previously proposed classiﬁcation (Table 1). Type I if NAA
is the predominant peak, type II if the Cho is the predominant
peak and type III if the predominant peak is not NAA or Cho.
Each type further sub-typing into A, B ad C according to spe-
ciﬁc spectral ﬁndings e.g. in types I and II if there is Lip peak,
it is given the subtype C. If No Lip peak it is given A or B
(according to Lac peak). Type III is subdivided differently, if
the predominant peak in the spectrum is Lipid, it is given
the subtype A, or B (according to Cho peak). Type IIIC (the
ﬂat spectrum), if the MRS does not detect metabolite peaks
at all (13,14).
2.2. Operative data
Operative approach was guided according to preoperative dif-
fusion MRI and MRI spectroscopy. All pituitary adenomas
operated by endoscopic trans-septal trans sphenoidal
approach where curettage and suction could remove most of
the midline tumor and different angles rigid endoscope enabled
surgeons for better visualization and inspection of sellar and
parasellar contents.
 Good evaluation of sphenoid sinus anatomy, deﬁning
sinus type (conchal, presellar, sellar), and sinus septa
whether midline or paramedian.
 Sellar localization was conﬁrmed intra-operatively by
the C-arm.
 Other sellar lesions which may need proximal vascular
control as meningioma, glioma, craniopharyngioma,
teratoma, dermoid operated by microscopic subfrontal
approach and frontal craniotomy.
 All patients kept at least one night at ICU for the
assessment of postoperative courses regarding con-
scious level, visual, clinical, the ﬂuid chart, electrolytes
disturbances and managing complications if any.2.3. Histopathological diagnosis
Our diagnosis was conﬁrmed pathologically after surgical
treatment.
Table 1 Determination of the type of pathological 1H-MRS (14,15).
Type of the pathological 1H-MR spectra Predominant peak Lac peak Lip peaks
IA NAA No No
IB NAA Yes No
IC (with mild elevation of Lip) NAA – Yes
IC (with moderate elevation of Lip) NAA – Yes
IIA Cho No No
IIB Cho Yes No
IIC (with mild elevation of Lip) Cho – Yes
IIC (with moderate elevation of Lip) Cho – Yes
IIIA Lip (Cho peak preserved) – Yes
IIIB Lip (reduced or absent Cho peak) – Yes
IIIC Absent any detectable metabolite peak
MR spectroscopy and diffusion MR imaging of neoplastic lesions 8612.4. Data analysis
Data analysis was performed using the SPSS (v15) statistical
software package. ADC values were expressed as mean ± SD.
Using ANOVA test as analytic tool for comparison of mean
ADC values among different histological diagnosis
(p value 6 0.001, considered signiﬁcant).
3. Results
This study included 30 patients with suprasellar lesions as
diagnosed on cMRI. They were 18 females (60%) and 12 males
(40%) and their age distribution ranged from 9 years to
55 years with a mean age of 24.6 ± 12.9 years. The most com-
mon age group was 20 to <30 years (10 patients). All our cases
were evaluated clinically. The most frequent clinical presenta-
tion was headache with visual disturbance as detected in 19/30
(63.3%) patients (Table 2).
According to imaging ﬁndings based on cMRI, MRS and
ADC different pathological entities were detected (Table 3).
On MRS, macroadenoma is characterized by a signiﬁcant
reduction in NAA, moderate elevation of Cho, reduced Cr
and frequent small Lip/Lac peaks. Seven tumors had type
IIC, two cases showed type IIIB, two cases showed type IIIC
and two cases had type IA. By diffusion MRI, 9 cases dis-
played hyperintense signal on DWI which is consistent with
restricted diffusion, while 4 cases displayed hypointense signal
of unrestricted diffusion, the mean ADC value in the 9 cases
was 0.68 ± 0.36 (mean ± SD), compared to the normal gray
matter of the adjacent temporal lobe (Fig. 1).
Five cases were diagnosed as craniopharyngiomas on cMRI
depending on characteristic MR imaging features. On MRS, 3
cases showed type IIC spectrum with a broad Lip peak (Fig. 2).
One case showed signiﬁcant decrease of all metabolites,Table 2 Main clinical presentations in the 30 studied cases.
Clinical presentation No. of patients (%)
Headache with visual disturbances 19(63.3%)
Headache with recurrent resistant vomiting 6(20%)
Isolated bilateral visual disturbance 2(6.6%)
Gigantism 1(3.3%)
Acromegaly 2(6.6%)displayed type IIIC spectrum, while the last case revealed
prominent choline peak, mild lactate with no detected lip peak
(type IIB). Heterogeneous hypointense signal on DWI and
hyperintense signal on the ADC map (Fig. 2). The mean
ADC value was 1.91 ± 0.2 (mean ± SD) · 103 mm2/s in 4
cases while the last case that displayed type IIB MR spectrum
had a lower ADC value (1.4 ± 0.15 · 103 mm2/s) and was
proved pathologically to be of glial origin after surgical
removal (Table 3).
Regarding the diagnosed cases of glial origin tumor; one of
them was operated and underwent radiotherapy. The primary
diagnosed cases showed type IIB spectrum with the prominent
metabolite peak being Cho (Fig. 3), however the operated case
showed no Cho peak but there is prominent lip peak which
could be attributed to radiotherapy changes. The glial supra-
sellar tumors displayed heterogeneous signal on DWI and
had ADC values of 1.57 ± 0.15 (mean ± SD) · 103 mm2/s
(Fig. 3).
Five cases of meningioma were diagnosed on c MRI, but on
MRS, the diagnosis was conﬁrmed in 2 cases that showed type
IIC spectrum with an elevated Alanine peak (at 1.49 ppm), one
case showed type IIIB, which is the case of recurrent meningi-
oma under radiotherapy in a patient with neuroﬁbromatosis
type II while 2 cases revealed characteristic type IIC with no
alanine peak.
The mean ADC value in 3 cases of meningiomas was
1.075 ± 0.17 (mean ± SD) · 103 mm2/s with no diffusion
restriction on DWI which is consistent with typical types,
but the 2 cases with no alanine peak revealed restricted diffu-
sion pattern with ADC value of 0.7 ± 36, this explained false
positive diagnosis of meningioma on cMRI as they were diag-
nosed as macroadenomas and conﬁrmed histopathologically
(Table 3).Table 3 Pathological types of the 30 cases based on cMRI,
MRS and ADC.
The lesion Based on cMRI
no. of patients %
Based on MRS
and ADC no.
of patients %
Pituitary macroadenoma 13(43.3%) 15(50%)
Craniopharyngioma 5(16.6%) 4(13.3%)
Glioma 4(13.3%) 5(16.6%)
Meningioma 5(16.6%) 3(10%)
Germinoma 3(10%) 3(10%)
Fig. 1 A case of macroadenoma. 55-Year-old female patient presented with persistent headache. (A) Coronal T2WI revealed relatively
hyperintense sellar SOL with supra-sellar and left para-sellar extension. (B) Coronal post Gd DTPA revealed homogeneous enhancement
of the lesion. (C) Axial DWI revealed intermediate signal intensity of the lesion. (D) Axial ADC map revealed intermediate signal intensity
of the lesion with ADC value = 1.1 denoting tumor with low cellularity (ﬁrm adenoma). (E) Single voxel MRS revealed type IIB:
predominant Cho, reduced NAA, and mild Lip peak.
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Fig. 2 A case of craniopharyngioma. 9-Year-old female presented with severe persistent headache. (A) Axial T2WI showing abnormal
signal intensity lobulated lesion at the sellar and suprasellar region displays heterogeneous hyperintense signal. (B) Axial DWI showed
heterogeneous hypointense supra-sellar lesion. (C) Axial ADC maps displayed heterogeneous hyperintensity of the lesion with ADC
value = 1.7 · 103 mm2/s. (D) Single voxel MRS revealed type IIC spectrum of the lesion by showing predominant peak of Cho, reduced
NAA and broad Lip peak.
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of Cho, decreased NAA and Cr, along with prominent Lip
peak type IIC. In DWI, the lesions displayed a hyperintense
signal on DWI and intermediate signal intensity on the ADC
map and had mean an ADC value of 1 · 103 mm2/s (Fig. 4).
Using ANOVA as a statistical analytic tool = 27.5
p< 0.001. ADC values can signiﬁcantly be correlated to the
histological diagnosis (p< 0.001), for example, If the ADC
value is 1.88 · 103 mm2/s this strongly points to craniopha-
ryngioma, but with the ADC value of 0.6 · 103 mm2/s this
strongly points to macroadenoma (Table 4).4. Discussion
MRI can provide an initial diagnosis of an intracranial mass
with a success rate of 30–90% (15). Proton MR Spectroscopyhas been categorized as a safe diagnostic technique that can
improve the non-invasive categorization of brain disorders
and that they are starting to have a role in everyday clinical
medicine (16).
In the present study we used long TE in MRS imaging as it
allows good differentiation between lactate, lipid and alanine
and lower base line distortion, similarly Mikhail et al. (17)
and Majos et al. (18) used long TE. On the other hand, Fan
et al. (11) used a short echo time in his study for brain gliomas
and metastasis. Added that, metabolites such as myoinositol,
are readily observed at short echo time only.
In our study we used single voxel MRS technique. Single
voxel is considered to have major advantages when spatial res-
olution is not required. The advantages include short time
requirement, quicker data processing for obtaining quantita-
tive assessment and better magnetic ﬁeld homogeneity
(11,17). On the other hand Haughton et al. (16), recommended
Fig. 3 A case of optic chiasma glioma. 17-Year old male patient presented with headache, vomiting, and bilateral diminution of vision
and left sided proptosis. (A and B) Axial and coronal T2WI displayed hyperintense supra-sellar lesion with extension through the left optic
foramen into the optic nerve with subsequent proptosis. (C) Axial T1WI post Gd DTPA revealed intense uniform enhancement of the
lesion. (D) Axial DWI revealed hypointensity of the lesion, but relatively hyperintense to CSF excluding cystic lesion and support solid
lesion with low cellularity. (E) Axial ADC map revealed inhomogeneous hyperintensity of the lesion with ADC value = 1.4 · 10–3 mm2/s.
(F) Single voxel MRS revealed type IIC spectrum: elevated Cho reduced NAA and mild Lip peak.
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Fig. 4 A case of supra-sellar germinoma. 5-Year old female patient presented with bilateral diminution of vision. (A) Sagittal T1WI with
Gd DTPA revealed supra-sellar SOL with mild inhomogeneous enhancement. (B) Axial DWI revealed slight hyperintense signal. (C)
Axial ADC map showed intermediate signal intensity of the lesion with ADC value = 1.0 · 10–3 mm2/s. (D) Single voxel MRS revealed
type IIIA spectrum: predominant peak of Lip, high choline peak, and decreased NAA and only residual Cr.
Table 4 Showing comparison of mean ADC values among
different histological diagnosis.
No. X± SD (range) Median
Macroadenoma 15 0.7 ± 0.28 (0.37–1.3) 0.6
Craniopharyngioma 4 1.9 ± 0.2 (1.7–2.2) 1.88
Glioma 5 1.57 ± 0.15 (0.4–1.7) 1.6
Meningioma 3 1.07 ± 0.17 (0.9–1.3) 1.05
Germinoma 3 1.0 ± 0.1(0.9–1.1) 1.00
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voxel can provide information on tumor heterogeneity and
inﬁltration not available by single voxel spectroscopy.
The most common suprasellar tumor in our study was the
macroadenoma which revealed type IIC MRS metabolite pro-
ﬁle pattern was in agreement with previous studies of Falini
et al. (9), who stated that adenomas had pathological 1H-
MRS type IIC which was characterized by a signiﬁcant reduc-
tion of the NAA peak, residual Cr peak, moderate elevation of
Cho and infrequent presence of small Lip and Lac peaks. In
our study all adenomas with type II were exclusively type IIC.
866 F.F. Mohammad et al.Regarding DWI we found a heterogeneous signal and dif-
ferent values for ADC according to their consistency. Nine
cases displayed hyperintense signal on DWI which is consistent
with restricted diffusion and had a mean ADC value of
0.68 ± 0.36 (mean ± SD), while 4 cases displayed hypointense
signal of unrestricted diffusion with higher ADC values due to
low cellularity. Our results were similar to Pierallini et al. (19)
who stated that macroadenomas are of soft consistency with
ADC values (0.66 ± 0.1) · 103 mm2/s, intermediate consis-
tency with ADC values (0.84 ± 0.08) · 103 mm2/s and hard
consistency with ADC values (1.36 ± 0.26) · 103 mm2/s.
Moreover, Rogg et al. (20) stated in their studies that the
DW signal and ADC values probably depend on the phase
of hemorrhage and/or infarction in the pituitary gland or the
pituitary adenoma.
In craniopharyngiomas cases we found MR spectra type
IIC in three cases and III C in one case with a signiﬁcant
decrease of all metabolites, but we did not investigate any
cysts. We focused the voxel over the solid portions of the
tumor avoiding any cystic components. While Mikhail et al.
(17) proved that 80% of craniopharyngioma showed type IIIC
spectrum. He added that it seems that such a metabolic pattern
resulted from the presence of calciﬁcations and microcysts
within the investigated volume of tissue. Elevated lipid peak
with only small quantities of other metabolites correlated with
the histological ﬁndings revealing high amounts of cholesterol
in the cyst ﬂuid.
Additionally craniopharyngiomas appeared as heteroge-
neously hypointense on DWI with high ADC values. In the
current study, average ADC values for craniopharyngiomas
was (1.91 ± 0.2) · 103 mm2/s. in agreement with Sener
et al. (21).
MR spectra for our glioma cases were typically character-
ized by decreased NAA, Cr peaks and increase of Cho peak.
Three tumors had pathological 1H-MR spectra type II: 1 –
type IIA, 2 – type IIB, and 3 – type IIC. The recurrent tumor
showed type IIIB spectrum. In agreement with Mikhail et al.
(17), but in disagreement regarding the spectrum of the recur-
rent glioma that showed type IIIC. Hypointense signal of low
grade pilocytic astrocytoma is useful in the differential diagno-
sis because MR spectroscopy shows a high Cho level, low
NAA and Lac peak despite the benign histology of the tumor
(16).
On DWI, all of them showed hypointensity on DWI and
hyperintensity on ADC map with mean ADC
(1.57 ± 0.15) · 103 mm2/s which is consistent with low
tumeral cellularity in consistence with Murakami et al. (22)
who found that ADC values in pilocytic astrocytoma is often
higher than 1.5 · 103 mm2/s. High ADC value probably
reﬂects relatively lower cellularity, a lower nuclear-to-cytoplas-
mic ratio and a high concentration of glycosaminoglycans,
which is highly hydrophilic causing the shift of water molecules
in the extracellular matrix.
Two meningioma cases in our study showed type IIC spec-
trum and an elevated alanine peak (at 1.49 ppm). These ﬁnd-
ings were partially consistent with those of Majos et al. (18)
who stated that alanine is the most characteristic metabolite
of meningioma, thus he considered it as a marker for meningi-
oma. One case of meningioma showed type IIIB which was a
recurrence under radiotherapy in a patient with neuroﬁbroma-
tosis type II. This is in agreement with Sumer (23) who alsostated that post radiation lesions show a large peak between
0 and 2 ppm, indicating cell necrosis products.
Regarding the DWI of the meningioma cases appeared
slightly hypointense in 3 out of 5 cases with an average
ADC value of 1.07 ± 17 · 103 mm2/s, while two cases with
no alanine peak on MRS showed restricted diffusion with a
mean ADC (0.7 ± 36 · 103 mm2/s,), so the diagnosis as
meningioma on cMRI was incorrect and they were diagnosed
as macroadenoma on MRS and DWI. Our results near the
results reported by Okamoto et al. (24) in their study as they
found that 66% of meningiomas (8 out of 12 cases) appeared
isointense on DWI while partial hyperintensity was noted in
the other cases (33%), while other authors found that the
signal characteristics of meningiomas on DWI are variable
(20).
Regarding germinoma cases in our study, typically charac-
terized type IIC with moderate elevation of Lip, which was
characterized by the absence of NAA peak, residual Cr peak,
and signiﬁcant elevation of Cho. This is in agreement with the
authors (17). On DWI, we found them hyperintense on DWI
(b1000) with an ADC value of 0.9–1.0 · 103 mm2/s. On the
contrary Annette et al. (25) found that the majority of germi-
noma cases were isointense (54.4%) on DWI with normal dif-
fusion and an ADC value of 0.94 ± 0.54 · 10–3 mm2/s, while
36% were hyperintense on DWI with restricted diffusion and
a mean ADC value of 0.69 ± 0.74 · 103 mm2/s. They also
found no signiﬁcant correlation between the histological com-
ponents and the ADC values.
In the current study, MRS and diffusion-weighted imaging
are proved to be helpful as a non-invasive modality for the
diagnosis of supra-sellar lesions. ADC values were statistically
signiﬁcant when correlated to the histological diagnosis
(p< 0.001).
5. Conclusion
MRS and diffusion-weighted MRI are considered important
diagnostic tools complementary to cMRI examination and
promise to contribute to pre-surgical evaluation and discrimi-
nation between different suprasellar lesions.
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